Mauro Giuffre
Overview
Explore the profile of Mauro Giuffre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zucchini N, Capozzella E, Giuffre M, Mastronardi M, Casagranda B, Croce S, et al.
Obes Surg
. 2024 Sep;
34(10):3627-3638.
PMID: 39271585
Purpose: Metabolic bariatric surgery (MBS) became integral to managing severe obesity. Understanding surgical risks associated with MBS is crucial. Different scores, such as the Metabolic and Bariatric Surgery Accreditation and...
2.
3.
Aversano A, Lissandrini L, Macor D, Carbone M, Cassarano S, Marino M, et al.
Diagnostics (Basel)
. 2024 Jun;
14(12).
PMID: 38928665
Background: Metastatic pancreatic lesions (MPLs) are relatively uncommon, constituting 2 to 5% of all pancreatic tumors. They often manifest as solitary lesions without distinct clinical symptoms, usually identified incidentally during...
4.
Giuffre M, Kresevic S, You K, Dupont J, Huebner J, Grimshaw A, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(3):417-418.
PMID: 38884531
No abstract available.
5.
Giuffre M, Kresevic S, Pugliese N, You K, Shung D
Liver Int
. 2024 May;
44(9):2114-2124.
PMID: 38819632
Large Language Models (LLMs) are transformer-based neural networks with billions of parameters trained on very large text corpora from diverse sources. LLMs have the potential to improve healthcare due to...
6.
Giuffre M, Kresevic S, You K, Dupont J, Huebner J, Grimshaw A, et al.
Aliment Pharmacol Ther
. 2024 May;
60(2):144-166.
PMID: 38798194
Background: Interest in large language models (LLMs), such as OpenAI's ChatGPT, across multiple specialties has grown as a source of patient-facing medical advice and provider-facing clinical decision support. The accuracy...
7.
Giuffre M, Dupont J, Visintin A, Masutti F, Monica F, You K, et al.
Hepatol Int
. 2024 Apr;
PMID: 38664292
Introduction: Non-selective beta-blockers (NSBB) are used for primary prophylaxis in patients with liver cirrhosis and high-risk varices (HRVs). Assessing therapeutic response is challenging due to the invasive nature of hepatic...
8.
Kresevic S, Giuffre M, Ajcevic M, Accardo A, Croce L, Shung D
NPJ Digit Med
. 2024 Apr;
7(1):102.
PMID: 38654102
Large language models (LLMs) can potentially transform healthcare, particularly in providing the right information to the right provider at the right time in the hospital workflow. This study investigates the...
9.
Giuffre M, Merli N, Pugliatti M, Moretti R
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542310
Nonalcoholic fatty liver disease (NAFLD) exponentially affects the global healthcare burden, and it is currently gaining increasing interest in relation to its potential impact on central nervous system (CNS) diseases,...
10.
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffre M, et al.
Clin Microbiol Rev
. 2024 Feb;
37(2):e0013523.
PMID: 38421181
SUMMARY infection (CDI) is one of the major issues in nosocomial infections. This bacterium is constantly evolving and poses complex challenges for clinicians, often encountered in real-life scenarios. In the...